Bausch & Lomb (BLCO) Depreciation & Amortization (CF) (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Depreciation & Amortization (CF) came in at $102.0 million in Q2 2026, down 4.67% YoY from $107.0 million in Q2 2025, and up 0.99% on a QoQ basis from $101.0 million in Q1 2026.
Bausch & Lomb (BLCO) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $102.0 million in Q2 2026.
- Quarterly Depreciation & Amortization (CF) fell 4.67% year-over-year to $102.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $411.0 million (down 4.2% YoY) and the FY2025 annual result came in at $421.0 million, down 3.44% from the prior year.
- Depreciation & Amortization (CF) grew to $102.0 million in Q2 2026, from $101.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $116.0 million in Q4 2023 to a low of $82.0 million in Q3 2023.
- A 5-year average of $101.2 million and a median of $101.5 million in 2026 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) dropped 11.83% — and 2024, when it surged 34.15%.
- Tracing BLCO's Depreciation & Amortization (CF) over 5 years: stood at $93.0 million in 2022, then climbed by 24.73% to $116.0 million in 2023, then declined by 8.62% to $106.0 million in 2024, then dropped by 6.6% to $99.0 million in 2025, then gained by 3.03% to $102.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $102.0 million (Q2 2026), $101.0 million (Q1 2026), and $99.0 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 102.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 102.00 Mn |
| Jun 30, 2026 | 102.00 Mn |
| Mar 31, 2026 | 101.00 Mn |
| Mar 31, 2026 | 101.00 Mn |
| Dec 31, 2025 | 99.00 Mn |
| Dec 31, 2025 | 99.00 Mn |
| Sep 30, 2025 | 109.00 Mn |
| Sep 30, 2025 | 109.00 Mn |
| Jun 30, 2025 | 107.00 Mn |
| Jun 30, 2025 | 107.00 Mn |
| Mar 31, 2025 | 106.00 Mn |
| Mar 31, 2025 | 106.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Sep 30, 2024 | 110.00 Mn |
| Sep 30, 2024 | 110.00 Mn |
| Jun 30, 2024 | 110.00 Mn |
| Jun 30, 2024 | 110.00 Mn |
| Mar 31, 2024 | 110.00 Mn |
| Mar 31, 2024 | 110.00 Mn |